Oculis Holding AG

OCS · NASDAQ

$7.49+$0.17 (+2.32%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $7.32

Latest news

Press releaseOct 20, 2:00 AM ETGlobe Newswire
Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting
Press releaseOct 19, 2:00 AM ETGlobe Newswire
Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease
Press releaseOct 7, 1:59 AM ETGlobe Newswire
Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day
Press releaseOct 1, 2:00 AM ETGlobe Newswire
Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS
Press releaseAug 24, 4:00 AM ETGlobe Newswire
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
NewsAug 10, 3:37 AM ET
Oculis Acquires Accure's Privosegtor And ACT-02 Assets In Deal Worth $3.8M Upfront Cash And Up To 2,050,000 Shares
Press releaseAug 10, 3:30 AM ETGlobe Newswire
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
Press releaseAug 6, 4:05 PM ETGlobe Newswire
Oculis Reports Q2 2026 Financial Results and Provides Company Update
NewsAug 3, 4:01 AM ET
Oculis To Submit IND For Privosegtor In Acute MS Relapses In Q4 2026, Backed By Positive FDA Pre-IND Guidance And Prior Optic Neuritis Data
Press releaseAug 3, 4:00 AM ETGlobe Newswire
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
NewsJul 17, 8:02 AM ETAvi Kapoor
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
Press releaseJun 23, 5:46 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
Press releaseJun 18, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
Press releaseJun 16, 5:03 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
Press releaseJun 11, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
Press releaseJun 8, 9:00 AM ETPRNewswire
Oculis Holding AG (OCS) Securities Fraud Investigation - Levi & Korsinsky
Press releaseJun 4, 4:31 PM ETBusiness Wire
OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm
Press releaseJun 4, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
Press releaseJun 3, 9:00 AM ETBusiness Wire
OCS Investor Alert: Levi & Korsinsky Investigates Oculis Holding AG (OCS) for Potential Securities Fraud
Press releaseJun 2, 4:59 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
Press releaseJun 2, 9:00 AM ETPRNewswire
OCS SHAREHOLDER INVESTIGATION: SueWallSt Investigates Oculis Holding AG for Possible Securities Law Violations
Press releaseJun 1, 3:31 PM ETPRNewswire
Oculis Holding AG Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Oculis Holding AG (OCS)
NewsJun 1, 10:12 AM ETVandana Singh
Why Is Oculis Stock Sinking Monday?
NewsMay 29, 5:05 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
NewsJan 6, 10:07 AM ETAvi Kapoor
Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday
NewsDec 19, 8:02 AM ETAvi Kapoor
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Press releaseNov 10, 4:05 PM ETGlobe Newswire
Oculis Reports Q3 2025 Financial Results and Provides Company Update
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
NewsAug 21, 4:32 AM ET
Earnings Scheduled For August 21, 2025
NewsAug 20, 11:02 AM ET
Uncovering Potential: Oculis Holding's Earnings Preview
NewsApr 17, 8:49 AM ETAvi Kapoor
Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Press releaseMar 11, 4:30 PM ETGlobe Newswire
Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update
NewsJan 10, 12:26 PM ETAvi Kapoor
TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday
Press releaseOct 8, 5:00 AM ETBusiness Wire
Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board
NewsJul 15, 8:14 AM ETAvi Kapoor
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting

Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease

Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day

Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS

First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis

Oculis Acquires Accure's Privosegtor And ACT-02 Assets In Deal Worth $3.8M Upfront Cash And Up To 2,050,000 Shares

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

Oculis Reports Q2 2026 Financial Results and Provides Company Update

Oculis To Submit IND For Privosegtor In Acute MS Relapses In Q4 2026, Backed By Positive FDA Pre-IND Guidance And Prior Optic Neuritis Data

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses

Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

Oculis Holding AG (OCS) Securities Fraud Investigation - Levi & Korsinsky

OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

OCS Investor Alert: Levi & Korsinsky Investigates Oculis Holding AG (OCS) for Potential Securities Fraud

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

OCS SHAREHOLDER INVESTIGATION: SueWallSt Investigates Oculis Holding AG for Possible Securities Law Violations

Oculis Holding AG Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Oculis Holding AG (OCS)

Why Is Oculis Stock Sinking Monday?

12 Health Care Stocks Moving In Friday's After-Market Session

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Oculis Reports Q3 2025 Financial Results and Provides Company Update

Earnings Scheduled For November 6, 2025

Earnings Scheduled For August 21, 2025

Uncovering Potential: Oculis Holding's Earnings Preview

Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update

TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session